• Home
  • About IonChannelCentral

Ion channel News

Entries RSS | Comments RSS
  • Tags

    agonist amitiza Amlodipine Anesiva Angiotensin II AT1 antagonist AstraZeneca ca channel Calcium Channel chloride channel CIC-2 CIC2 cl channel Clevelox Clevidipine Cleviprex CV therapeutics Icagen Ion Channel KCa3.1 K Channel Licensing lidocaine lubiprostone Merck na channel Novartis phase II Potassium Channel preclinical Regulatory Research RU-0211 RU0211 Senicapoc Sodium channel SPI-0211 Sucampo takeda The Medicines Company TRPV1 UCB Vanilloid voltage gated VR1

US and WO patent update for the week ending 05/23

Posted on May 23, 2008 by crimsoncanary

US and WO ion channel patents have been updated for this week at IonChannelCentral.com

Filed under: Uncategorized | Tagged: Ion Channel, patents

« TRPV4 Channel Agonist GSK1016790A Induces Urinary Bladder Contraction and Hyperactivity Pipex license Oral Flupirtine Patent from the McLean Hospital »

Leave a Reply

Click here to cancel reply.

  • Calendar

    • May 2008
      M T W T F S S
      « Apr   Jun »
       1234
      567891011
      12131415161718
      19202122232425
      262728293031  
  • Blogroll

    • CrimsonCanary.com
    • IonChannelCentral
    • KinaseCentral
    • PharmaCompanyPipelines

Blog at WordPress.com. Theme: Digg 3 Column by WP Designer